Annual Congress Vienna 2003

Saturday, 27.09.2003
Sunday, 28.09.2003
Monday, 29.09.2003
Tuesday, 30.09.2003
Wednesday, 01.10.2003

Citations should be made in the following way: Authors. Title. Eur Respir J 2003; 22: Suppl. 45, abstract number.

Material from 2003:

3196 Abstracts
374 Slide presentations

Material from 2003: Show

Newer and alternative non-steroidal treatments for asthmatic inflammation

Oral Presentation
Chairs: L. Fabbri (Modena, Italy), K. F. Rabe (Leiden, The Netherlands)

Download all media

Treatment of co-morbid allergic asthma and perennial allergic rhinitis with the anti-IgE agent omalizumab A. M. Vignola, J. Bousquet, J. Maspero, H. Fox, S. Hedgecock, M. Blogg (Palermo, Italy; Montpellier, France; Buenos Aires, Argentina; Horsham, United Kingdom)
Efficacy of omalizumab in patients with moderate-to-severe allergic asthma that is poorly controlled on GINA (1998) treatment step 3 or 4 J. Bousquet, R. Niven, G. Ayre, H. Fox, M. Blogg (Montpellier, France; Manchester, Horsham, United Kingdom)
Anti-IgE therapy with omalizumab decreases exacerbations in patients with poorly controlled moderate-to-severe allergic asthma F. Chung, G. Kunkel, S. Ramos, G. Ayre, H. Fox, M. Blogg (London, Horsham, United Kingdom; Berlin, Germany; Oviedo, Spain)
Effect of treatment with anti-IgE antibody on airway inflammation in mild asthma R. Djukanovic, S. J. Wilson, M. Kraft, N. Jarjour, M. Steel, F. K. Chung, W. Bao, A. Fowler Taylor, J. Mathews, W. W. Busse, S. T. Holgate, J. V. Fahy (Southampton, United Kingdom)
The novel selective PDE4 inhibitor roflumilast: early onset of efficacy in asthma M. Aubier, G. B. Nagy, R. Sauer, C. Schmid-Wirlitsch, A. Albrecht, D. Bredenbroker (Paris, France; Budapest, Hungary; Ulm, Konstanz, Germany)
Roflumilast, a selective phosphodiesterase 4 inhibitor, shows efficacy and safety in the long-term treatment of asthma E. D. Bateman, J. L. Izquierdo, N. Vetter, C. Schmid-Wirlitsch, D. Bredenbroeker (Cape Town, South Africa; Guadalaljara, Spain; Vienna, Austria; Konstanz, Germany)
Effect of an inhaled adenosine A_2A agonist on the allergen induced late asthmatic response B. Luijk, M. van den Berge, H. A. Kerstjens, D. D. Postma, J. W. J. Lammers (The Netherlands)